EP377 - ECE_3691 - FABP4 and fatty liver index in obesity: insights across metabolic health categories
The findings support FABP4 as a potential biomarker reflecting both metabolic phenotype and liver steatosis in obesity and further studies are needed to clarify the role of FABP4 as a non-invasive indicator of NAFDL.